Beta Bionics, Inc. (BBNX) Income from Continuing Operations (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Income from Continuing Operations data on file, last reported at 21895000.0 in Q1 2026.

• Quarterly Income from Continuing Operations fell 35.1% year-over-year to 21895000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 66438000.0 (down 34.94% YoY) and the FY2025 annual result came in at 60749000.0, down 46.94% from the prior year.
• Income from Continuing Operations declined to 21895000.0 in Q1 2026 per BBNX's latest filing, from 13466000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 8314000.0 in Q1 2024, with the low at 21895000.0 in Q1 2026.
• Average Income from Continuing Operations over 3 years is 13776222.22, with a median of 13466000.0 recorded in 2025.
• The widest YoY moves for Income from Continuing Operations: up 11.42% in 2025, down 94.92% in 2025.
• Beta Bionics' Income from Continuing Operations stood at 12086000.0 in 2024, then decreased by 11.42% to 13466000.0 in 2025, then tumbled by 62.59% to 21895000.0 in 2026.
• Business Quant data shows BBNX's Income from Continuing Operations at 21895000.0 in Q1 2026, 13466000.0 in Q4 2025, and 14210000.0 in Q3 2025.